Cardiovascular benefits of primary prevention statins were evident even in healthy older adults

STAREE trial will give its verdict on primary prevention statins in people ages 70 and up

MUNICH — Statin therapy cut risk for major adverse CV events by 30% for healthy older adults compared with placebo, but did not extend disability-free survival, according to data…